Zelmic has been in operation since 2003 in Lund, Sweden. During that time we have developed one product per year up to manufacture according to cGMP and to clinical phase II testing and brought the same number into other types of preclinical proof of concept tests. During the same period we have filed 10 patent applications protecting the products in development.

The personnel of Zelmic has been working with drug delivery technologies since 1971 and has put oral, parental and dermatological products on the market.